| On July 4, we sent you an important email about a bustling medtech stock trading at $3.50. It's topped $8. That means it's up 130% in just five weeks. Two legends discuss the details in this briefing. Don't miss out on its profitable run-up for another minute. The July 4 note we sent you about it is below...
Critical Follow-Up: Stock now up to $8 (up 130%) Institutional investors are plowing into one American medtech... That's because it's hugely disruptive (already in all top 100 hospitals)... and has a patent moat protecting future profits. In fact, in the most recent quarterly report, these funds added to their stakes despite the 2022 market downturn: - Dynamic Advisor Solutions: 15,210 new shares
- Cetera Advisor Networks: 1,856 new shares
- Arizona State Retirement System: 2,363 new shares
- Principal Financial Group: 2,994 new shares
- ProShare Advisors: 3,874 new shares.
And legendary medtech investor Larry Robbins personally loaded up on 500,000 new shares worth $1.87 million. Yet you can get your hands on this award-winning medtech today for a cheaper price than Robbins gladly paid. Yours in smart speculation,  Karim Rahemtulla, Head Fundamental Tactician
Monument Traders Alliance P.S. Hurry, as this stock has jumped from $2.92 on June 16 to as high as $3.50 since (+20%). Urgent details in this special briefing.
* Please note... the stock has now topped $8 (up 130% in the last six weeks) | 
Post a Comment
Post a Comment